Literature DB >> 12681368

G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression.

Scott D Sorensen1, P Jeffrey Conn.   

Abstract

Metabotropic glutamate receptors (mGluR) serve important neuromodulatory roles at glutamatergic synapses to shape excitatory neurotransmission. Recent evidence indicates that the desensitization of mGluRs is an important determinant in regulating the functions of these receptors. The present results demonstrate that G protein-coupled receptor kinases (GRKs), which are known to regulate the desensitization of many G protein-coupled receptors, regulate both the expression and function of mGluR5 in a heterologous expression system. This regulatory event is limited to members of the GRK2 family since GRK4 family members do not elicit the same effects on mGluR5. Kinase activity is shown to be required for GRK-mediated regulation of mGluR5. Furthermore, the ability of GRK2 to regulate mGluR5 is dependent, at least in part, on the presence of threonine 840 in the carboxyl terminus of mGluR5. These studies identify novel roles for GRKs in regulating mGluR5 that may serve to further shape the function of these receptors in neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681368     DOI: 10.1016/s0028-3908(03)00053-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  23 in total

Review 1.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

2.  Fragile X syndrome: (What's) lost in translation?

Authors:  Kevin Miyashiro; James Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

3.  Phosphorylation-independent regulation of metabotropic glutamate receptor 5 desensitization and internalization by G protein-coupled receptor kinase 2 in neurons.

Authors:  Fabiola M Ribeiro; Lucimar T Ferreira; Maryse Paquet; Tamara Cregan; Qingming Ding; Robert Gros; Stephen S G Ferguson
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

4.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

5.  Intracellular mGluR5 can mediate synaptic plasticity in the hippocampus.

Authors:  Carolyn A Purgert; Yukitoshi Izumi; Yuh-Jiin I Jong; Vikas Kumar; Charles F Zorumski; Karen L O'Malley
Journal:  J Neurosci       Date:  2014-03-26       Impact factor: 6.167

Review 6.  Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.

Authors:  Shen Yin; Colleen M Niswender
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

7.  Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice.

Authors:  Cora H Nijboer; Cobi J Heijnen; Hanneke L D M Willemen; Floris Groenendaal; Gerald W Dorn; Frank van Bel; Annemieke Kavelaars
Journal:  Brain Behav Immun       Date:  2009-11-22       Impact factor: 7.217

Review 8.  Phosphorylation of group I metabotropic glutamate receptors (mGluR1/5) in vitro and in vivo.

Authors:  Li-Min Mao; Xian-Yu Liu; Guo-Chi Zhang; Xiang-Ping Chu; Eugene E Fibuch; Lucy S Wang; Zhenguo Liu; John Q Wang
Journal:  Neuropharmacology       Date:  2008-06-10       Impact factor: 5.250

9.  Astrocyte GRK2 as a novel regulator of glutamate transport and brain damage.

Authors:  Cora H Nijboer; Cobi J Heijnen; Vincent Degos; Hanneke L D M Willemen; Pierre Gressens; Annemieke Kavelaars
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

Review 10.  Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.

Authors:  Mark E Obrenovich; Ludis A Morales; Celia J Cobb; Justin C Shenk; Gina M Méndez; Kathryn Fischbach; Mark A Smith; Eldar K Qasimov; George Perry; Gjumrakch Aliev
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.